Successful Methods for Switching from a Benzodiazepine Receptor Agonist to a Dual Orexin Receptor Antagonist for the Treatment of Insomnias.

Clin Psychopharmacol Neurosci · 2025 · PMC12559944 · PMID 41139604

Europe PMC DOI

hedged sentence

0.0760

closest p · 1.5× alpha

0.0760

boldest claim

The sentences

a nonsignificant trendp = 0.076so close (0.05 < p ≤ 0.1)

Our first logistic regression analysis revealed that in the SUV group, the basal dose of BZRAs showed a nonsignificant trend (β = 0.500, p = 0.076).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.